CannLabs Delays Disclosures to its Shareholders and the SEC

CannLabs Logo

Publicly-traded CannLabs (OTC:  CANL), which operates what the company claims is the leading Colorado cannabis testing lab, continues to generate significant controversy.  Last week, it disclosed that its founder and President, Gen Murray, had been fired “for cause” and had resigned from the Board of Directors.  Earlier this week, New Cannabis Ventures uncovered an investigation by the Marijuana Enforcement Division that charged the company with 44 violations.

On October 6th, the company issued a press release that finally admitted that its former CEO, Mark Mirken, had returned to that role as well as assuming the role of Chairman of the Board.  The p.r. disclosed that the former Chairman, Mark Rogers, had left the Board of Directors as well, though the date of these management changes wasn’t disclosed. Mirken’s departure was never announced to shareholders except through a 10-Q filing with the SEC on July 8th:

Effective June 15, 2015, Mark Mirken resigned as Chief Executive Officer of CannLabs, Inc. As part of his separation agreement, Mr. Mirken has agreed to forfeit 2 million shares of restricted stock which were awarded to him through his employment agreement. The Company has entered into a consulting agreement with Mr. Mirken , whereby he will be paid $5,000 per month beginning August 1, 2015 for his business development efforts and he will serve as Vice-Chairman to the Board of Directors.

His successor, Scott McPherson, who also held the role of CFO, left on July 16th, as disclosed in an 8-K filing with the SEC on July 22nd, with no successor named:

On July 16, 2015, Scott McPherson, Chief Executive Officer and Chief Financial Officer of CannLabs, Inc. (the “Company”), provided notice of his decision to resign from his positions as an officer of the Company effective immediately.

Gen Murray, who was still serving as President at that time, signed this SEC document.

The company filed a long overdue 8-K filing after the close of trading on October 7th that suggested Mirken had returned as CEO on August 7th, two days after the resignation of Chairman Mark Rogers but also the previously undisclosed departure of Director Kenneth Johnson:


CannLabs has not only failed to keep its shareholders informed, but it appears to have violated the rules of the Securities & Exchange Commission, which require information of this nature to be disclosed within four business days.  The departures of the directors as well as the appointment of Mirken to CEO should have been revealed over 8 weeks ago.  Similarly, the termination of Gen Murray was disclosed outside of the proper time-frame.

The CannLabs saga appears to be a tragic tale of all that can go wrong with reverse-mergers, a speedy process to begin trading as a public company.  At this point, the company is delinquent in its filings, having still not filed financials for Q2, and it has failed to update its shareholders regarding several material events in a timely manner.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter